BackAytu BioPharma Overview

Aytu BioPharma Receivables

Track Aytu BioPharma's receivables ($24M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$24.49M
↓ 31.64% YoYΔ $-11.34M vs prior year quarter

Peer average

Loading

Aytu BioPharma Receivables History

Loading

Aytu BioPharma vs. peers: Receivables Comparison

Loading

Aytu BioPharma Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Aytu BioPharma (AYTU) FAQ

As of the most recent data (March 2026), AYTU shows a receivables of $24M. That compares with $36M in the prior-year period — down 31.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AYTU's receivables is now $24M (was $36M) — a 31.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Aytu BioPharma is outperforming or lagging.

Tracking AYTU's receivables over time shows whether Aytu BioPharma is scaling, shrinking, or reshaping that part of the business. The current reading is $24M That compares with $36M in the prior-year period — down 31.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Aytu BioPharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $24M) with ownership activity and broader fundamentals.

Aytu BioPharma's receivables is $24M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.